ROCKVILLE, MD, December 10, 2015 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced new appointments and changes to the Company’s management team. Effective immediately, Dr. Thomas F. Miller has been promoted to President & Chief Executive Officer. Dr. Aprile Pilon has assumed responsibility for leading and advancing the Company’s secretoglobin platform in the role of Executive Vice President and Chief Scientific Officer. Therabron has also named Anita Fauchier as its Vice President of Regulatory Affairs and Quality Assurance. Dr. Pilon and Ms. Fauchier will report to Dr. Miller, effective immediately.

For more information: Click Here